Recently, Beijing Guanqiao Medical Technology Co., Ltd. announced the completion of the A round of financing, with a financing amount of tens of millions of yuan. This round of financing was exclusively invested by the Beijing Medical and Health Industry Investment Fund, and old shareholders such as Yuansheng Venture Capital, Beijing Yishang Huicheng, Aoki Capital, and Renhe Capital continued to support it. The financing will mainly be used to invest in R&D and innovation, promote new product development and technological breakthroughs, and lay out new clinical treatment fields; it will also further expand production scale, improve production capacity and supply chain efficiency; and at the same time expand overseas markets and lay out sales networks to promote international registration and certification compliance.

Recently, Beijing Guanqiao Medical Technology Co., Ltd. announced the completion of the A round of financing, with a financing amount of tens of millions of yuan. This round of financing was exclusively invested by the Beijing Medical and Health Industry Investment Fund, and old shareholders such as Yuansheng Venture Capital, Beijing Yishang Huicheng, Aoki Capital, and Renhe Capital continued to support it. The financing will mainly be used to invest in R&D and innovation, promote new product development and technological breakthroughs, and lay out new clinical treatment fields; it will also further expand production scale, improve production capacity and supply chain efficiency; and at the same time expand overseas markets and lay out sales networks to promote international registration and certification compliance.